These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22322337)

  • 1. The current challenges for vaccine development.
    Oyston P; Robinson K
    J Med Microbiol; 2012 Jul; 61(Pt 7):889-894. PubMed ID: 22322337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adjuvants: current challenges and future approaches.
    Wilson-Welder JH; Torres MP; Kipper MJ; Mallapragada SK; Wannemuehler MJ; Narasimhan B
    J Pharm Sci; 2009 Apr; 98(4):1278-316. PubMed ID: 18704954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond empiricism: informing vaccine development through innate immunity research.
    Levitz SM; Golenbock DT
    Cell; 2012 Mar; 148(6):1284-92. PubMed ID: 22424235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New adjuvants for human vaccines.
    Mbow ML; De Gregorio E; Valiante NM; Rappuoli R
    Curr Opin Immunol; 2010 Jun; 22(3):411-6. PubMed ID: 20466528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal Vaccine Development Based on Liposome Technology.
    Bernasconi V; Norling K; Bally M; Höök F; Lycke NY
    J Immunol Res; 2016; 2016():5482087. PubMed ID: 28127567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whither vaccines?
    Rodrigues CMC; Pinto MV; Sadarangani M; Plotkin SA
    J Infect; 2017 Jun; 74 Suppl 1():S2-S9. PubMed ID: 28646957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerating next-generation vaccine development for global disease prevention.
    Koff WC; Burton DR; Johnson PR; Walker BD; King CR; Nabel GJ; Ahmed R; Bhan MK; Plotkin SA
    Science; 2013 May; 340(6136):1232910. PubMed ID: 23723240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in vaccine development.
    Moyle PM
    Curr Protoc Microbiol; 2015 Feb; 36():18.1.1-18.1.26. PubMed ID: 25641099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The path forward.
    De Gregorio E
    Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter from the editor.
    Ellis R; Riedmann EM
    Hum Vaccin Immunother; 2013 Apr; 9(4):721. PubMed ID: 24091588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Subunit vaccines--antigens, carriers, conjugation methods and the role of adjuvants].
    Jarząb A; Skowicki M; Witkowska D
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1128-43. PubMed ID: 24379254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity and new adjuvants.
    Mutwiri G; Gerdts V; Lopez M; Babiuk LA
    Rev Sci Tech; 2007 Apr; 26(1):147-56. PubMed ID: 17633299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vaccines: bridging research, development and production.
    Demirjian A; Levy O
    Expert Rev Vaccines; 2008 Nov; 7(9):1321-4. PubMed ID: 18980535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern Vaccine Adjuvant/Formulation--Session 9: Adjuvants.
    Dalençon F
    Hum Vaccin Immunother; 2013 Sep; 9(9):2013-4. PubMed ID: 23938771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines, our shared responsibility.
    Pagliusi S; Jain R; Suri RK;
    Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.
    Mortellaro A; Ricciardi-Castagnoli P
    Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
    Banday AH; Jeelani S; Hruby VJ
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.
    Arakawa T
    Expert Rev Vaccines; 2011 Jan; 10(1):1-5. PubMed ID: 21162613
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of vaccines and vaccinations: Challenges and opportunities for modelers.
    Curtiss R
    Math Biosci Eng; 2011 Jan; 8(1):77-93. PubMed ID: 21361401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.